KNB vs. SPI, MGP, SBI, TLY, CNSL, VRCI, CIZ, ODX, APTA, and SUN
Should you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Totally (TLY), Cambridge Nutritional Sciences (CNSL), Verici Dx (VRCI), Cizzle Biotechnology (CIZ), Omega Diagnostics Group (ODX), Aptamer Group (APTA), and Surgical Innovations Group (SUN). These companies are all part of the "medical" sector.
Kanabo Group vs.
Kanabo Group (LON:KNB) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.
Kanabo Group has a beta of 3.04, indicating that its stock price is 204% more volatile than the S&P 500. Comparatively, Spire Healthcare Group has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
Spire Healthcare Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Spire Healthcare Group had 2 more articles in the media than Kanabo Group. MarketBeat recorded 2 mentions for Spire Healthcare Group and 0 mentions for Kanabo Group. Spire Healthcare Group's average media sentiment score of 0.34 beat Kanabo Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.
3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 50.4% of Spire Healthcare Group shares are owned by institutional investors. 37.0% of Kanabo Group shares are owned by insiders. Comparatively, 34.7% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Spire Healthcare Group received 356 more outperform votes than Kanabo Group when rated by MarketBeat users.
Spire Healthcare Group has a net margin of 1.96% compared to Kanabo Group's net margin of -717.63%. Spire Healthcare Group's return on equity of 3.82% beat Kanabo Group's return on equity.
Spire Healthcare Group has a consensus target price of GBX 300, indicating a potential upside of 62.27%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts plainly believe Spire Healthcare Group is more favorable than Kanabo Group.
Summary
Spire Healthcare Group beats Kanabo Group on 14 of the 17 factors compared between the two stocks.
Get Kanabo Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kanabo Group Competitors List
Related Companies and Tools
This page (LON:KNB) was last updated on 4/19/2025 by MarketBeat.com Staff
Buy KNB Stock Free KNB Stock Alerts